Chiron Investment Management, LLC Vertex Pharmaceuticals Inc Transaction History

Chiron Investment Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $4.75 Million - $5.68 Million	13,841 Added 2113.13%	14,496 $5.9 Million
Q3 2023 Nov 13, 2023	SELL	$338.18 - $362.46 $7.34 Million - $7.87 Million	-21,714 Reduced 97.07%	655 $227,000
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $4.04 Million - $4.53 Million	12,859 Added 135.22%	22,369 $7.87 Million
Q1 2023 May 15, 2023	BUY	$283.23 - $323.1 $2.66 Million - $3.03 Million	9,392 Added 7959.32%	9,510 $3 Million
Q4 2022 Feb 13, 2023	SELL	$285.76 - $321.48 $19.8 Million - $22.2 Million	-69,156 Reduced 99.83%	118 $34,000
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $1.09 Million - $1.21 Million	-3,972 Reduced 5.42%	69,274 $20.1 Million
Q2 2022 Aug 12, 2022	SELL	$234.96 - $292.55 $3.26 Million - $4.06 Million	-13,875 Reduced 15.93%	73,246 $20.6 Million
Q1 2022 May 13, 2022	BUY	$221.42 - $260.97 $19.3 Million - $22.7 Million	87,121 New	87,121 $22.7 Million
Q4 2020 Feb 11, 2021	SELL	$207.01 - $276.09 $6.89 Million - $9.19 Million	-33,274 Closed	0 $0
Q3 2020 Nov 18, 2020	BUY	$255.65 - $303.1 $4.24 Million - $5.03 Million	16,603 Added 99.59%	33,274 $9.06 Million
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $3.76 Million - $4.93 Million	16,671 New	16,671 $4.84 Million
Q2 2019 Aug 14, 2019	SELL	$164.61 - $190.37 $22.5 Million - $26.1 Million	-136,907 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$163.73 - $194.7 $22.4 Million - $26.7 Million	136,907 New	136,907 $25.2 Million

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Chiron Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Chiron Investment Management, LLC with notifications on news.